Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Buchanan

Showing results (61-70 of 298) with videos related to

Pageof 30
Sort By:
Journal for Immunotherapy of Cancer|September 22, 2021
DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancerQi Zou, Xiaolin Wang, Donglin Ren, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2017
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
Gastroenterology|October 5, 2014
Association between molecular subtypes of colorectal cancer and patient survivalAmanda I Phipps, Paul J Limburg, John A Baron, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
American Journal of Epidemiology|June 15, 2026
Evaluating statistical models for overdispersed multi-omics data: a multiplex immunofluorescence case studyClaire E Thomas, Evertine Wesselink, Yasutoshi Takashima, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2012
BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristicsAmanda I Phipps, Daniel D Buchanan, Karen W Makar, et al.
Human Pathology|August 24, 2014
Should the grading of colorectal adenocarcinoma include microsatellite instability status?Christophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
European Journal of Human Genetics : EJHG|June 3, 2026
Constitutional methylation of the MLH1 promoter: a case series including tumors not typically caused by Lynch SyndromeLise Graversen, Jannie Assenholt, Inge Søkilde Pedersen, et al.
Cancers|April 30, 2021
Epigenetic Drift Association with Cancer Risk and Survival, and Modification by SexChenglong Yu, Ee Ming Wong, Jihoon Eric Joo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Pageof 30

Showing results (61-70 of 298) with videos related to

Sort By:
Pageof 30
Journal for Immunotherapy of Cancer|September 22, 2021
DNA methylation-based signature of CD8+ tumor-infiltrating lymphocytes enables evaluation of immune response and prognosis in colorectal cancerQi Zou, Xiaolin Wang, Donglin Ren, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2017
Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
Gastroenterology|October 5, 2014
Association between molecular subtypes of colorectal cancer and patient survivalAmanda I Phipps, Paul J Limburg, John A Baron, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|February 2, 2018
Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1Daniel D Buchanan, Jenna R Stewart, Mark Clendenning, et al.
American Journal of Epidemiology|June 15, 2026
Evaluating statistical models for overdispersed multi-omics data: a multiplex immunofluorescence case studyClaire E Thomas, Evertine Wesselink, Yasutoshi Takashima, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 18, 2012
BRAF mutation status and survival after colorectal cancer diagnosis according to patient and tumor characteristicsAmanda I Phipps, Daniel D Buchanan, Karen W Makar, et al.
Human Pathology|August 24, 2014
Should the grading of colorectal adenocarcinoma include microsatellite instability status?Christophe Rosty, Elizabeth J Williamson, Mark Clendenning, et al.
European Journal of Human Genetics : EJHG|June 3, 2026
Constitutional methylation of the MLH1 promoter: a case series including tumors not typically caused by Lynch SyndromeLise Graversen, Jannie Assenholt, Inge Søkilde Pedersen, et al.
Cancers|April 30, 2021
Epigenetic Drift Association with Cancer Risk and Survival, and Modification by SexChenglong Yu, Ee Ming Wong, Jihoon Eric Joo, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|October 30, 2015
Clinicopathologic Risk Factor Distributions for MLH1 Promoter Region Methylation in CIMP-Positive TumorsA Joan Levine, Amanda I Phipps, John A Baron, et al.
Pageof 30